Silver-amplified fluorescence immunoassay via aggregation-induced emission for detection of disease biomarker

Ze-Hui Sun,Xuan-Xuan Zhang,Duo Xu,Jie Liu,Ru-Jia Yu,Chao Jing,Huan-Xing Han,Wei Ma
DOI: https://doi.org/10.1016/j.talanta.2020.121963
IF: 6.1
2021-04-01
Talanta
Abstract:<p>Development of simple, robust, and reliable detection strategy of disease biomarkers holds tremendous promise for early clinical diagnosis and prognosis of diseases. In this work, through combining a silver nanoparticle (AgNP) linked immunoassay and aggregation induced emission (AIE)-based fluorogenic Ag<sup>+</sup> probe, we developed a silver-amplified fluorescence immunoassay for the detection of disease biomarkers. This method overcame the intrinsic limitations of enzymes as the dissolution of AgNPs generated numerous Ag<sup>+</sup>, which could switch on the fluorogenic Ag<sup>+</sup> probe driven by tetrazolate-Ag<sup>+</sup> complexation. As a proof of concept, our method could be used for determining α-fetoprotein (AFP) with a linear relationship in concentrations ranging from 0.1 ng mL<sup>−1</sup> to 5 μg mL<sup>−1</sup> and a low limit of detection of 42 pg mL<sup>−1</sup>. Our method was successfully confirmed for the detection of AFP in real serum samples from hepatocellular carcinoma (HCC) patients, demonstrating the great potential for clinical diagnosis.</p>
chemistry, analytical
What problem does this paper attempt to address?